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Abstract
While the human T-cell leukemia virus type 1 (HTLV-1) is the etiologic agent of adult T-cell
leukemia/lymphoma (ATL), to date, its close relative HTLV-2 is not associated with ATL or other
types of malignancies. Accumulating evidence shows that HTLV-1 Tax1 and HTLV-2 Tax2 have
many shared activities, but the two proteins have a limited number of significantly distinct activities,
and these distinctions appear to play key roles in HTLV-1 specific pathogenesis. In this review, we
summarize the functions of Tax1 associated with cell survival, cell proliferation, persistent infection
as well as pathogenesis. We emphasize special attention to distinctions between Tax1 and Tax2.
Background
Adult T-cell leukemia/lymphoma (ATL) is an aggressive
form of leukemia/lymphoma characterized by the malig-
nant proliferation of CD4 T cells infected with human T-
cell leukemia virus type 1 (HTLV-1) [1-4]. HTLV-1 infec-
tion also causes a neurodegenerative disease termed
HTLV-1-associated myelopathy/tropical spastic parapare-
sis (HAM/TSP) [5,6]. HTLV-1 belongs to the delta-retrovi-
rus family, and it infects currently 10-20 million people in
the world, especially in southwestern Japan, Africa, the
Caribbean Islands and South America [7]. HTLV-1 trans-
mission mainly occurs from mother to child through
breast milk [8]. After the transmission and infection,
HTLV-1 immortalizes the infected CD4 T-cells; and this
immortalization establishes a life-long persistent infec-
tion in a host [9,10]. The immortalization of infected T-
cells is likely to be dependent on cytokines [11] including
interleukin (IL)-2, and perhaps also occurs in cytokine-
independent (or less-dependent) ways as discussed later.
Indeed, HTLV-1 transforms primary human CD4 T-cells
in an IL-2-dependent as well as IL-2-independent manner
in vitro. This transformation event of infected T-cells alone
is, however, not sufficient for ATL development, since
only a fraction of HTLV-1 infected individuals (approxi-
mately 5%) suffer ATL after a long latency period (60 years
on average). Thus, both multiple genetic and epigenetic
changes [12] in infected T-cells and the deterioration of
host immune system are thought to be prerequisites for
ATL development.
Intriguingly, a closely related delta-retrovirus, human T-
cell leukemia virus type 2 (HTLV-2), does not cause any
leukemia or lymphoma in infected people in spite of its
ability to immortalize in vitro human T-cells in an IL-2-
dependent manner as effectively as HTLV-1 [13]. Moreo-
ver, the association of HTLV-2 infection with HAM/TSP is
quite rare. Thus, HTLV-2 should be regarded as defective
in promoting certain steps of leukemogenesis and neuro-
logic disease development, and this virus may be a useful
comparative tool for understanding the pathogenic activ-
ities of HTLV-1. In addition, HTLV-3 and HTLV-4 have
recently been identified from bushman hunters in central
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Africa, although the association of these viruses to human
diseases needs further investigations [14-16].
In addition to structure genes, gag, pol, and env, HTLV-1
encodes several non-structural genes including p12, p13,
p30, Rex, and Tax (Figure 1) [17]. Among them, HTLV-1
Tax (Tax1) plays a central role in the immortalization of
infected T-cells and the persistence of infection in a host.
Tax1 immortalizes primary human T-cells in an IL-2
dependent manner, and transforms a T cell line CTLL-2
from IL-2 dependent growth into IL-2-independent
growth [18-20]. In addition, Tax1 induces anchorage
independent growth of a Rat-1 fibroblast cell line, and
such cells can develop tumors in nude mice [21]. These
results suggest that Tax1 has both immortalizing and
oncogenic potentials.
Tax1 was originally identified as a transcriptional activator
that interacts with a triplicated Tax-responsive enhancer in
the 5' long terminal repeat (LTR) of the HTLV-1 genome
[22,23]. In addition, through interacting with a number of
cellular proteins, Tax1 functions in the survival of HTLV-
1-infected T-cells, in cell cycle progression, cell growth,
and in induced genomic instability [23-25]. All these Tax1
functions are thought to work cooperatively to transform
HTLV-1 infected T-cells and have pivotal roles in the
development of HTLV-1 associated diseases. Among
them, Tax1-induced genomic instability is undoubtedly
involved in ATL development, but we will not discuss this
topic because it has been reviewed well elsewhere [26-28].
Here, we will focus on the functions of Tax1 in cell sur-
vival, proliferation, and pathogenesis, with an emphasis
on distinctions between HTLV-1 and HTLV-2 Tax pro-
teins.
Activation of the NF- B pathway
The NF-κB family of transcription factors, including RelA,
c-Rel, RelB, NF-κB1 (p50 and its precursor p105), NF-κB2
(p52 and its precursor p100), plays a central role in
immune functions, such as innate and adaptive responses
to pathogens, survival of lymphocytes, and lymphoid tis-
sue development [29]. On the other hand, aberrant NF-κB
activation is implicated in the genesis of many types of
cancer, especially hematologic malignancies such as
leukemia, lymphoma, and myeloma [30]. There are two
NF-κB-signaling pathways that regulate overlapping, but
distinct sets of cellular genes; and these two pathways are
called the canonical and the noncanonical NF-κB path-
ways. Inflammatory cytokines, genotoxic stress, antigens,
and toll like receptor (TLR) stimulation activate the
canonical pathway, whereas a subset of TNF family mem-
bers, such as CD40L, lymphotoxin-β, BAFF, RANKL, and
TWEAK activate the noncanonical pathway. While the
activation of the canonical pathway results in the degrada-
tion of its inhibitor IκB and the translocation of the p50/
RelA complex into the nucleus, the activation of the non-
canonical pathway results in the processing of p100/RelB
into p52/RelB and the translocation of the latter into the
nucleus.
NF-κB activity is tightly controlled in normal T cells, and
it is transiently activated in certain circumstances such as
during immune stimulation. By contrast, NF-κB is consti-
tutively active in HTLV-1-infected T cells [31-34]. This
constitutive NF-κB activation is mediated by Tax, and the
activity is essential for T cell transformation by HTLV-1
and HTLV-2. For instance, HTLV-1 and HTLV-2 carrying
mutant tax1 and tax2 genes defective for NF-κB activation,
can not immortalize primary human T cells [35,36] (how-
ever, in some cases of Tax over expression, NF-κB activity
is not needed to immortalize primary human T cells [37]).
In addition, Tax1 NF-κB mutants cannot transform CTLL-
2 and Rat-1 cells, consistent with the importance of NF-κB
activation for Tax1-induced cell growth promotion
[20,38,39].
Mechanism of NF- B activation by Tax
Both Tax1 and Tax2 activate the canonical NF-κB pathway
through interacting with multiple NF-κB regulators.
While the full scheme of canonical NF-κB activation by
Tax has not been elucidated yet, the activation of the IKK
complex by Tax through binding with its scaffold subunit
IKKγ (NEMO) is a central event. The above conclusion
was established based on the observation that the loss of
NEMO completely abrogates the activation of NF-κB by
Tax1 [40,41]. A MAP3K, TAK1, stimulates IKK activity
upon various stimuli such as TLR, IL-1, and anti-CD3
Structures of HTLV-1 and HTLV-2 Figure 1
Structures of HTLV-1 and HTLV-2. A comparison of 
HTLV-1 genes with those of HTLV-2. Some HTLV-2 non-
structural genes such as APH-2, the equivalent protein to 
HTLV-1 HBZ, are indicated as HBZ and are named using 
HTLV-1 nomenclature in this figure.
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stimulation [42]. Tax1, through interacting with TAK1,
increases TAK1 kinase activity [43]. Thus, Tax1 functions
as an adaptor, mediating the TAK1-IKK interaction
through binding to both molecules.
Tax1 undergoes several posttranslational modifications,
including phosphorylation, acetylation, sumoylation,
and ubiquitination [44-50]. Among these, Tax1 ubiquiti-
nation is crucial for its binding to NEMO and for the sub-
sequent NF-κB activation [48]. Tax1 polyubiquitination is
predominantly composed of K63-linked chains, and such
ubiquitination is dependent on the E2 ubiquitin conju-
gating enzyme, Ubc13 [48]. In addition, another Tax1
binding protein TAX1BP1 forms a ternary complex with
the E3 ubiquitin ligase Itch and the ubiquitin-editing
enzyme A20. The TAX1BP1-A20 deubiquitinase complex
is a negative regulator of NF-κB activity induced by
inflammatory cytokines; Tax1 can disrupt this inhibitory
complex to thereby trigger constitutive NF-κB activation
in HTLV-1-infected cells [51,52]. Recently, it was found
that NEMO-Related Protein (NRP/Optineurin) binds to
both Tax1 and TAX1BP1; this newly-described interaction
can positively modulate Tax1 ubiquitination and NF-κB
activation [53].
Tax1 specific activation of NF- B2
In addition to the canonical NF-κB pathway, Tax1 acti-
vates the noncanonical NF-κB pathway [54]. Tax1 simul-
taneously binds to the IKK complex and NF-κB2/p100,
leading to IKKα mediated p100 phosphorylation and sub-
sequent p100 processing into p52 [54]. Interestingly,
HTLV-2 Tax2 cannot induce p100 processing into p52
when transiently expressed in the Jurkat T-cell line,
although Tax2 can activate the canonical NF-κB pathway
to a level comparable to Tax1 [55]. The major defect of
Tax2 in p100 processing is an inability of Tax2 to interact
with p100 [55]. The Tax1 region encompassing amino
acids 225-232, overlapping with the leucine zipper like
region (LZR), is responsible for Tax1-mediated p100
processing and p52 nuclear translocation (Figure 2) [56].
Since Tax1 LZR is not required for interaction with p100,
Tax1 interaction with IKK complex and p100 is not suffi-
cient for p100 processing. Thus, an as-yet-unidentified
molecule which associates with the Tax1 LZR might be
involved in the activation of the noncanonical NF-κB
pathway.
The transforming activity of Tax1 towards CTLL-2 is much
higher than that of Tax2, and such increased activity is
partly mediated through Tax1-specific activation of the
noncanonical NF-κB pathway [55-58]. For instance, the
exogenous expression of an activator of the noncanonical
pathway, a constitutively active NF-κB inducing kinase
(NIK), restores the transforming activity of Tax2 to a level
equivalent to that of Tax1 [55]. Interestingly, the require-
ment of NF-κB2 activation in Tax1 transformation
appears to be T-cell specific, since the NF-κB2 activation
by Tax1 is not needed in the transformation of Rat-1 [59].
Given the fact that aberrant activation of the noncanoni-
cal NF-κB pathway is associated with the development of
mature T-cell leukemia and lymphoma [60], these results
suggest that the activation of the noncanonical NF-κB
pathway by Tax1 plays a role in HTLV-1 specific pathogen-
esis.
NF- B activation in T-cell transformation
Continued cell cycle progression and resistance to apop-
tosis are two fundamental functions associated with the
transformation of HTLV-1 infected T cells. NF-κB activa-
tion by Tax1 is critically involved in both functions. When
expressed in G1- arrested primary human T cells, Tax1
induces cell cycle progression from the G1 to S phase
through activation of E2F transcription factors [61]. The
ability of Tax1 to promote cell-cycle progression is at least
partially mediated through the induction of cyclin D2 and
Cdk6 via the NF-κB pathway [62]. The activation of both
the canonical and noncanonical NF-κB pathways by Tax1
is involved in this process, since knockdown of either
RelA or NF-κB2/p100 by short hairpin RNA reduces Tax1-
induced cell-cycle progression [62]. It is noteworthy that
in addition to this NF-κB dependent function, Tax1 acti-
vates Cdk4/6 through direct interaction with Cdk4, Cdk6,
and Cdk inhibitors such as p16INK4A and p15INK4B [63-
Two regions of Tax1 are responsible for increased trans- forming activity relative to Tax2 in CTLL-2 cells Figure 2
Two regions of Tax1 are responsible for increased 
transforming activity relative to Tax2 in CTLL-2 
cells. (A) The amino acid sequences of the Tax LZR of 
HTLVs and STLVs. A bar indicates the identical amino acids 
of Tax from the other six viruses to that of Tax1. The leucine 
residues constituting a putative LZ structure are marked by 
circle. (B) The amino acid sequences in the C-terminal ends 
of the respective Tax proteins. The PBMs are surrounded by 
squares.
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69]. Thus, the cell cycle progression induced by Tax1
requires both the induction of cell cycle regulators in an
NF-κB-dependent manner and their subsequent activa-
tions in an NF-κB-independent manner.
Tax1 has been shown to confer resistance to apoptosis
through inducing anti-apoptotic proteins such as Bcl-xL,
survivin, cFLIP, xIAP, cIAP1, and cIAP2 in a NF-κB
dependent manner [70-75]. Both the noncanonical and
canonical NF-κB pathways appear to play positive roles in
the inhibition of apoptosis. For instance, cell lines estab-
lished from large granular leukemia developed in Tax1
transgenic mice are resistant to apoptosis inducers,
whereas knockdown of either NF-κB1 or NF-κB2 aug-
ments apoptosis, through reducing the expression of the
xIAP, cIAP1, cIAP2, and cFLIP [74].
Inductions of cytokines, chemokines and receptors
Tax1 upregulates the expression of genes encoding
cytokines, chemokines, cell surface ligands, and their
receptors, in an NF-κB, AP-1, CREB/ATF and/or NFAT
dependent manner. They include IL-2 receptor (IL-2R) α-
chain, IL-9, IL-13, IL-15/IL-15R, IL-21/IL-21R, IL-8, CCL2,
CCL5, CCL22, CCR9, CXCR7, CD40, OX40/OX40L, and
4-1BB/4-1BBL [76-94]. Among these, the IL-2R α-chain is
crucially important for T-cell immortalization by Tax,
since the immortalized cells are dependent on IL-2 for
their growth.
Transient transfection studies showed that Tax1 induces
the expression of IL-2 through the transcription factor
NFAT in Jurkat cells treated with either TPA or ionomycin
[95]. Together with the constitutive expression of a func-
tional IL-2R caused by Tax1 in HTLV-1 infected T-cells,
these results hypothesized that the aberrant activation of
an IL-2/IL-2R autocrine loop contributes to the prolifera-
tion of infected and leukemic T-cells in vivo. However,
subsequent studies revealed that most of HTLV-1-infected
and leukemic cell lines derived from ATL patients except
for HUT102, do not express significant levels of IL-2
[96,97]. Thus, the roles of the IL-2/IL-2R autocrine loop in
HTLV-1 mediated T-cell transformation in vitro and the
leukemogenesis in vivo are unclear. Unlike HTLV-1, HTLV-
2-infected T-cell lines constitutively produce IL-2 in the
culture supernatant, and Tax2 without any additional
stimulation activates IL-2 gene expression through NFAT
in Jurkat cells [98]. Moreover, cyclosporine A (an inhibi-
tor of NFAT) as well as anti-IL-2R antibodies inhibit the
proliferation of HTLV-2-infected T-cell lines [98]. These
results suggest that the IL-2/IL-2R autocrine loop is essen-
tial for proliferation of HTLV-2-infected cells, and such
Tax2-specific activity is a crucial factor for establishing
persistent HTLV-2 infection in vivo.
It is likely that other factors induced by Tax1 would be
beneficial for the survival and proliferation of HTLV-1
infected T-cells in vivo through regulating T-cell functions
such as cell survival, cell motility, adhesion, and tissue
distribution. For instance, OX40 and 4-1BB, by inducing
a cell to cell interaction, could further augment NF-κB
activity, making a positive feedback loop, which would be
important for the maintenance of NF-κB activity in HTLV-
1-infected cells that express a low level of Tax1 in vivo [99].
PDZ domain containing proteins
PDZ (PSD-95/Discs Large/ZO-1) domain containing pro-
teins bind to the PDZ domain binding motif (PBM)
which is typically present at the carboxyl-terminus of tar-
get proteins [100]. One major structural difference
between Tax1 and Tax2 is the presence of a PBM at the C-
terminus of Tax1, but not Tax2 (Figure 2). It has been
shown that deletion of the PBM from HTLV-1 (HTLV-1/
ΔPBM) abrogates the persistent HTLV-1 infection in rab-
bits, whereas the PBM is dispensable for IL-2-dependent
immortalization of primary human T-cells [101]. How
does the Tax1 PBM play a role in persistent HTLV-1 infec-
tion in vivo without affecting the IL-2-dependent immor-
talization of primary T-cells? Interestingly, the deletion of
PBM prominently reduces IL-2-independent growth of
CTLL-2 cells induced by Tax1 [57]. Taken into account
that the steady state level of IL-2 in vivo is generally too
low to support IL-2-induced T-cell proliferation, the
reduced requirement of IL-2 induced by Tax1 through
PBM may explain the selectively defective function of
HTLV-1/ΔPBM in vivo.
It is unclear how the Tax1 PBM contributes to inducing IL-
2-independent growth of T-cells. The addition of Tax1
PBM to the C-terminus of Tax2 in the context of HTLV-2
significantly increases the proliferation of primary human
T-cells infected with the virus in vitro [101]. Thus, Tax1
PBM may engage in the cell growth promoting activity of
Tax1. In addition, it should be noted that the Tax1 PBM
has an activity to induce micronuclei in Tax1 expressing
cells [101-103]. Thus, the Tax1 PBM may have an activity
associated with the genomic instability observed in HTLV-
1 infected cells.
Similar to the pathogenesis differences between HTLV-1
versus HTLV-2, limited subtypes of human papilloma
viruses (HPVs) such as HPV16 and 18 are associated with
cervical cancers. Interestingly, the E6 oncoproteins from
only high risk HPVs, but not low-risk HPVs have a PBM
[100]. A similar pattern of subtype specific oncogenesis is
also observed for human adenovirus type 9. Intriguingly,
the PBMs from the oncogneic HPV E6 and the adenovirus
E4-ORF1 can efficiently substitute for the Tax1 PBM in
transforming CTLL-2 cells (submitted for publication).
Thus, the targeting of PDZ domain containing proteins is
likely to contribute an important mechanism to cellular
transformation and pathogenesis by tumorigenic viruses.Retrovirology 2009, 6:117 http://www.retrovirology.com/content/6/1/117
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Tax1 has been reported to interact with several PDZ
domain containing proteins including Dlg1, Scribble,
MAGI-3, TIP-1, IL-16 precursor protein, and Erbin
[59,104-111]. Below, we discuss the possible involvement
of Dlg1 and Scribble in Tax1 function. These proteins are
believed to play important roles in the regulation of cell
polarity, proliferation, and apoptosis.
Dlg1
Dlg1 is a mammalian homologue of Drosophila discs-
large (dlg) and a member of the membrane-associated
guanylate kinase (MAGUK) family proteins [112].
Homozygous dlg mutations in Drosophila cause neoplas-
tic overgrowth of imaginal disc epithelia and embryonic
lethality, establishing dlg as a tumor suppressor gene in
Drosophila. In mammalian epithelial cells, Dlg1 localizes
at adherence junctions (AJ) and is involved in the estab-
lishment of AJ as well as tight junctions. Following T cell
receptor (TCR) activation in T cells, Dlg1 is transiently
translocated to the immune synapses where it functions as
a scaffold coordinating the activities of signaling proteins
such as Lck, Zap70, Vav, WASP, and p38 kinase [113-
116]. T cells from Dlg1 knockout mice show a hyperpro-
liferative response to TCR stimulation, although proximal
TCR signaling events such as tyrosine phosphorylaion of
signaling molecules, calcium mobilization, and IL-2 pro-
duction are indistinguishable from wild type T cells, indi-
cating that Dlg1 functions as a negative regulator of T cell
proliferation [117].
Consistent with its tumor suppressive activity, the overex-
pression of Dlg1 in NIH-3T3 cells induces cell cycle arrest
in G1, and this arrest can be overcome by Tax1 in a PBM
dependent manner, indicating that Tax1, through direct
binding, interferes with the growth-suppressive activity of
Dlg1 [106]. Although it has not been elucidated yet how
Tax1 inactivates Dlg1 function, Tax1 induces the hyper-
phosphorylation of Dlg1 by an unknown mechanism,
and alters its subcellular localization from the detergent
soluble to the detergent insoluble fraction [59]. Unlike
Tax1, E6 inactivates Dlg1 by ubiquitination mediated pro-
teosomal degradation [118]. Consistent with the fact that
Dlg1 deficiency in T cells augments cell proliferation,
Dlg1 knockdown by short hairpin RNA in CTLL-2 cells
augments Tax1 mediated transformation, although the
knockdown alone cannot rescue the transforming activity
of a Tax1 PBM mutant incapable of binding to Dlg1 [119].
These results suggest that the inactivation of Dlg1 is
required for Tax1 mediated transformation of CTLL-2, but
this is not sufficient; and other PDZ domain containing
proteins are involved in the activity of PBM.
Scribble
Scribble is a member of the LAP (leucine rich and PDZ
domain) family of proteins and functions as a cell polarity
protein in cooperation with Dlg1 [112]. Like dlg, loss-of-
function mutation of scrib in Drosophila results in aber-
rant proliferation and abnormal cell polarity/architecture
of epithelial cells, indicating a role for Scribble as a tumor
suppressor. In mammalian epithelial cells, Scribble and
Dlg1 also form a scaffolding complex, regulating apical-
basal polarity. In T cells, the Scribble complex regulates T
cell polarity and morphology during migration and
immunological synapse formation [115].
Tax1 binds to Scribble in a PBM dependent manner,
although one report suggests there are both PBM-depend-
ent and -independent modes of Tax1-Scribble binding
[107,108]. Scribble is diffusely localized at the plasma
membrane of HTLV-1-uninfected T-cell lines, whereas it
colocalizes with Tax1 as small or large aggregates at the
plasma membranes, suggesting that Tax1 induces aber-
rant clustering of Scribble, thereby altering its functions in
HTLV-1-infected cells [107,108]. Although Scribble is tar-
geted for ubiquitin mediated degradation by high-risk
HPV E6, there seems to be no obvious degradation of
Scribble in HTLV-1 transformed cells, suggesting that
alteration of the subcellular localization of Scribble by
Tax1 is the main mechanism to inactivate its function.
Scribble over expression in Jurkat cells suppresses TCR-
induced NFAT activity, and this suppression is relieved by
Tax1 in a PBM dependent manner, indicating that Tax1
interferes with Scribble function although the significance
of this finding in infected T-cells remains unclear [107].
While it is very likely that viral oncoproteins including
Tax1 inactivate the tumor suppressive functions of PDZ
domain proteins, it remains possible that they might pos-
itively utilize such PDZ proteins to transform cells. This
idea was raised in order to explain the function of E4-
ORF1, since the loss of Dlg1 apparently reduces the trans-
forming activity of E4-ORF1 [120]. By analogy, Tax1
might take advantage of PDZ domain containing pro-
tein(s) to localize at certain cellular organelles, such as cell
membranes, in order to activate signaling pathways
important for cell growth and survival. Thus, the under-
standing of the whole picture of Tax1 PBM function in
HTLV-1 mediated T-cell transformation is still incom-
plete, and further studies are needed.
Activation of PI3K and Akt pathway
PI3K and its downstream kinase Akt are activated in T cells
by many cytokines including IL-2; this pathway provides
cell survival and growth signals [121]. Activated PI3K
phosphorylates phosphatidylinositol 4,5-bisphosphate to
produce phosphatidylinositol 3,4,5-trisphosphate (PIP3)
which binds and activates Akt. Activated Akt in turn
phosohorylates its downstream substrates which are
involved in cell survival and cell growth. On the other
hand, PIP3 phosphatases, such as phosphatase and tensinRetrovirology 2009, 6:117 http://www.retrovirology.com/content/6/1/117
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homolog deleted on chromosome 10 (PTEN) and Src
homology 2 domain containing inositol polyphosphate
phosphatase-1 (SHIP-1), dephosphorylate PIP3 to down-
regulate Akt activity.
In many cancers, the PI3K/Akt pathway is aberrantly acti-
vated by several means, including the gain of function
mutation in PI3K and Akt, the loss of PTEN, and the con-
stitutive activation of upstream signaling molecules such
as the mutation of ras [122]. In both HTLV-1 transformed
and ATL cells, the PI3K/Akt pathway is constitutively
active [123,124]. LY294002 (an inhibitor of PI3K) or AKT
inhibitor II induces cell cycle arrest at G1 phase in HTLV-
1 transformed cells through p27/kip1 accumulation, and
they subsequently induce caspase-9 dependent apoptosis
[101]. These findings indicate that PI3K/Akt activation by
Tax1 is critically involved in the growth of HTLV-1-
infected T-cells [125].
Several distinct mechanisms for Tax1 to activate PI3K/Akt
have been reported. Tax1 frees a catalytic p110α subunit
of PI3K complex from an inhibitory subunit p85α
through direct binding to p85α [124]. Tax1 also down-
regulates the expression of PTEN and SHIP-1 through
RelA-mediated sequestration of the transcriptional coacti-
vator p300 from the promoters of PTEN and SHIP-1
[126]. In addition, Tax1 through the CREB/ATF-1 path-
way activates Akt in 293T cells, although in this setting the
precise mechanism remains unclear [127].
The mammalian target of rapamycin (mTOR) is one of the
crucial downstream targets of Akt which is used to pro-
mote cell survival and growth mainly through the stimu-
lation of translational initiation [128]. Rapamycin, an
inhibitor of mTOR kinase activity, inhibits the phosphor-
ylation of p70S6 kinase and 4E-BP1, thereby inducing
growth inhibition and G1 cell cycle arrest of HTLV-1
transformed cells. These findings are consistent with
mTOR activation being important for Tax-induced cell
cycle progression [129]. In addition to mTOR, AP-1, NF-
κB, β-catenin, and HIF-1 are activated by Tax1 through
PI3K/Akt in HTLV-1-infected T-cells, and these factors also
seem to be involved in HTLV-1 mediated T-cell transfor-
mation [124,125,127,130].
Paradoxical to the virus' transforming activity, Tax1
expression in or HTLV-1 infection of human cells (HeLa,
SupT1 T-cell line) has been observed in some settings to
induce cell cycle arrest at the G1 phase through the induc-
tion of p27/kip1 and p21/waf1 [131]. This is often associ-
ated with the premature activation of the anaphase-
promoting complex (APC) [132]. This type of growth
inhibition by Tax1 or HTLV-1 infection is abrogated by
elevated Akt activity [133]. These results suggest that Akt
activation by Tax1 in cells may not be sufficient to inacti-
vate p27/kip1 and p21/waf1 functions, and that addi-
tional inactivation of p27/kip1 and p21/waf1 by genetic
and/or epigenetic alterations could be essential for HTLV-
1 to transform T-cells. It should be noted that 8 to 9 weeks
after infection with HTLV-1, primary human T-cells can
start to proliferate [101]; this lag time may be due to the
interval of time needed to obtain genetic and/or epige-
netic changes in order to escape cell cycle arrest induced
by Tax1.
Tax3 and Tax4
Like HTLV-1 and HTLV-2, HTLV-3 and HTLV-4 encode
Tax3 and Tax4, respectively. In their cognate viruses, Tax3
and Tax4 could play major roles in T-cell immortalization
and persistent infection (Figure 2) [15,16]. Amino acid
comparisons show that Tax3, but not Tax4, has a PBM at
its C-terminus, and can bind to a PDZ domain derived
from Dlg4 [15]. In addition, Tax3 and Tax4 show more
homology to Tax2 than Tax1 in the LZR region which is
important for the noncanonical activation of NF-κB.
However, it has not been verified whether Tax3 and/or
Tax4 activate the noncanonical NF-κB pathway. There-
fore, the PBM and the LZR classify these four HTLVs into
at least three distinct groups. Taken together, the PBM and
LZR motifs could play significant roles in the respective
life cycles of the HTLVs and contribute to their pathogen-
esis.
HBZ
Although the tax gene plays central roles in the immortal-
ization and persistence of virus infected cells, its expres-
sion is inactivated in approximately 60% of in vivo ATL
cases by mutation of the coding region and/or the tran-
scriptional silencing through epigenetic mechanisms such
as DNA methylation of the 5' LTR [134-139]. These find-
ings suggest that Tax1 is not needed in the maintenance of
the leukemic stage in some ATL cases. The frequent inacti-
vation of the tax gene was originally interpreted to imply
the dispensability of any HTLV genes for the maintenance
of the leukemic stage in certain ATL cases. This was a rea-
sonable interpretation since the expression of viral genes
other than tax  was usually not detected in ATL cells.
Recent studies, however, showed that the HTLV-1 basic
leucine zipper factor (HBZ) encoded by the virus in an
antisense orientation may play a critical role in the malig-
nant proliferation of ATL cells (Figure 1) [140]. The
expression of HBZ gene is detected in all ATL cases, and
this is due to the usage of the promoter in the 3' LTR of
HTLV-1 gene which is not inactivated in the ATL cells
[141,142]. Short hairpin RNA mediated knockdowns of
HBZ expression in both ATL and HTLV-1 transformed cell
lines reduce their proliferation [141,143]. Moreover,
transgenic mice expressing HBZ under the control of the
CD4 promoter/enhancer display increased numbers of
CD4-positive T-cells in the spleen, and augmented prolif-Retrovirology 2009, 6:117 http://www.retrovirology.com/content/6/1/117
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eration of thymocytes after anti-CD3 stimulation [141].
Thus, these findings indicate that HBZ has a growth pro-
moting activity, and could be involved in the malignant
proliferation of ATL cells in vivo, although the precise
molecular mechanism for these findings is still unclear.
HTLV-2 also encodes a HBZ like protein, designated as the
antisense protein of HTLV-2 (APH-2) [144]. Interestingly,
unlike HBZ, APH-2 does not have a leucine zipper motif
which is essential for various HBZ functions. Thus, it is
important to study whether the HTLV-2 APH-2 protein
has a growth promoting activity in T-cells like HBZ in
order to understand better how these two viruses show
distinct pathogenicities.
Conclusion
This review article summarizes our current view pertain-
ing to the molecular mechanism(s) of HTLV-1 mediated
T-cell transformation and persistent infection. In our
opinion, these mechanism(s) shed light on viral patho-
genesis, and offer insights into differences in HTLV-1 Tax1
and HTLV-2 Tax2 function. Based on current information,
we propose the following simplified model (Figure 3)
which does not incorporate other potentially important
factors such as oncogenic microRNAs [145-147]. HTLV-1-
infected T-cells grow equivalently to HTLV-2-infected cells
in environments with sufficient amount of IL-2 or other T-
cell growth promoting cytokines in vivo, but HTLV-1
infected cells under conditions of low cytokines can grow
much more efficiently than HTLV-2-infected cells. Such
growth advantage of HTLV-1 infection would cause more
expansion of infected cells in vivo, resulting in increased
probability of acquiring genetic alterations, followed by
clonal expansion of altered cells, and eventually leading
to ATL development. It should be noted that high HTLV-
1 proviral load (high numbers of infected cells) is a
tightly-linked risk factor for the development of ATL. Such
cytokine-independent (or less-dependent) growth proper-
ties of HTLV-1 infected T-cells are mediated by Tax1, pos-
sibly cooperatively with HBZ. To induce IL-2-independent
growth of T-cells, Tax1 has two activities distinct from
Tax2: the activation of the noncanonical NF-κB2 pathway
and as-yet-uncharacterized signals through PDZ domain-
containing proteins. These two activities are already
known to play crucial roles in hematopoietic malignan-
cies including leukemia and lymphoma and carcinogene-
sis induced by high-risk HPVs. This model would also be
applicable to the pathogenesis of HAM/TSP, since high
proviral loads are also tightly-linked risk factors for HAM/
TSP. In HAM/TSP, the increased expansion of HTLV-1
infected T-cells would further raise high immune response
to the virus, especially to Tax1, resulting in the develop-
ment of diseases possibly through already proposed
autoimmune mechanism(s). Collectively, we believe that
further comparisons of Tax functions from the four
human HTLVs will promote greater understanding of viral
pathogenesis. In addition, therapies targeted against func-
tions specific to Tax1 could be promising for the treatment
of HAM/TSP and certain ATL patients.
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